VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,315 | -25.1% | 1,500 | -23.1% | 0.00% | -33.3% |
| Q1 2023 | $32,468 | +130.3% | 1,950 | +30.0% | 0.01% | +100.0% |
| Q4 2022 | $14,100 | +252.5% | 1,500 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $4,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | -20.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -28.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000 | -22.2% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $9,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | +12.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | -11.1% | 1,500 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $9,000 | -18.2% | 1,500 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $11,000 | -8.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +20.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -16.7% | 1,500 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $12,000 | -20.0% | 1,500 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $15,000 | +36.4% | 1,500 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $11,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |